Trobalt
Recall
|
Medicines
|
26/06/2017
The marketing authorization holder has informed its supplied customers in a letter dated 23.06.2017 that due to the global decision of the company, the marketing authorization of the medicinal product "Trobalt" will be withdrawn in all strengths. Therefore, a recall will be carried out at wholesalers and pharmacies from 01.07.2017.
| Name of the medicinal product | Trobalt 50 mg Filmtabletten Trobalt 100 mg Filmtabletten Trobalt 200 mg Filmtabletten Trobalt 300 mg Filmtabletten Trobalt 400 mg Filmtabletten |
|---|---|
| Marketing authorisation number(s) | EU/1/11/681/001-002 EU/1/11/681/004-005 EU/1/11/681/007-008 EU/1/11/681/009-010 EU/1/11/681/011-012 |
| Marketing authorisation holder | GSK - GlaxoSmithKline Pharma GmbH |
| Batch number(s) | Alle Chargen |
| Classification of the recall | 3 |
| BASG reference number | INS-640.001-2078 |
Further inquiry note
Page last modified:
12/07/2022